🇺🇸 FDA
Patent

US 9504736

Administration of serine protease inhibitors to the stomach

granted A61KA61K31/10A61K31/145

Quick answer

US patent 9504736 (Administration of serine protease inhibitors to the stomach) held by The Regents of the University of California expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/10, A61K31/145, A61K31/155, A61K31/185